3rd Quarter - Report

CAPITOL HILL STRATEGIES, LLC for BIOGEN INC

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

H.R. 6, 21st Century Cures Act, (multiple provisions including incentives for innovation to help expedite novel treatments and cures, enhancements to FDA capacity and resources, and promotion of precision therapies, potential offsets) Issues dealing with newborn screening. S. 1878, Advancing Hope Act of 2015 legislation that amends the Federal Food, Drug, and Cosmetic Act to expand the priority review voucher program for rare pediatric diseases to include treatments for sickle cell disease and pediatric cancers.

LobbyistCovered position, as disclosed
CHARLES M BRAIN Asst. to the President, Dp.Chief Staff W&M Cmte
HEATHER MCHUGH Legislative Director, Sen. Chuck Schumer
BEAU` SCHUYLER LD-CongTanner,LD-CongMcIntyre,SA-CongRose
A. J. WOJCIAK Senior Legislative Asst., Cong. Earl Pomeroy

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6 (114th), S. 1878 (114th)

Medicare/Medicaid MMM

CMS proposed rule potential and potential legislation that includes provisions that would alter payment policies under Medicare Part B for drugs and biologics

LobbyistCovered position, as disclosed
CHARLES M BRAIN Asst. to the President, Dp. Chief Staff W&M Cmte.
HEATHER MCHUGH Legislative Director, Sen. Chuck Schumer
BEAU` SCHUYLER LD-Cong. Tanner, LD-Cong. McIntyre, SA-Cong. Rose
A. J. WOJCIAK Senior Legislative Asst., Cong. Earl Pomeroy

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.